Intellia Therapeutics (NTLA) EBITDA Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | 13,218.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,218.00 |
| Dec 31, 2025 | 40,551.00 |
| Sep 30, 2025 | 11,938.00 |
| Jun 30, 2025 | 1,458.00 |
| Mar 31, 2025 | 66,866.00 |
| Dec 31, 2024 | -37,102.00 |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | -106,512.00 |
| Mar 31, 2024 | 34,298.00 |
| Dec 31, 2023 | 746,583.00 |
| Sep 30, 2023 | -89,089.00 |
| Jun 30, 2023 | -71,805.00 |
| Mar 31, 2023 | -14,625.00 |
| Dec 31, 2022 | -56,224.00 |
| Sep 30, 2022 | -63,026.00 |
| Jun 30, 2022 | -49,898.00 |
| Mar 31, 2022 | -114,409.00 |
| Dec 31, 2021 | -40,881.00 |
| Sep 30, 2021 | -2.36 Mn |
| Jun 30, 2021 | -76,107.00 |
| Mar 31, 2021 | -43,119.00 |
| Dec 31, 2020 | -26,956.00 |
| Sep 30, 2020 | 9,111.00 |
| Jun 30, 2020 | 7,017.00 |
| Mar 31, 2020 | -42,555.00 |
| Dec 31, 2019 | -6,692.00 |
| Sep 30, 2019 | -6,378.00 |
| Jun 30, 2019 | -6,410.00 |
| Mar 31, 2019 | 16,724.00 |
| Dec 31, 2018 | 8,203.00 |
| Sep 30, 2018 | -11,090.00 |
| Jun 30, 2018 | -4,091.00 |
| Mar 31, 2018 | -19,300.00 |